STERIS plc (STE) is likely to grow in the coming quarters, backed by the promising recovery potential in the AST (Applied Sterilization Technologies) segment. The company also benefits from the growing healthcare and pharmaceutical sectors, fueled by an aging population and strategic acquisitions like the BD assets purchase. Strong solvency buoys optimism.Meanwhile, headwinds such as foreign currency risks and macroeconomic challenges raise worry for the stock.In the past year, shares of this Zacks Rank #3 ...

STERIS plc (STE) is expected to release fourth-quarter fiscal 2024 results soon.Earnings Surprise HistorySTE has a strong earnings surprise history. The company beat earnings estimates in three of the trailing four quarters and missed once, the average surprise being 3.96%.In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.22, which exceeded the Zacks Consensus Estimate by 2.30%.Let’s look at how things have shaped up before this announcement.Factors at PlayHealthcareTh ...

AUSTIN, Texas, April 11, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has signed a definitive agreement to acquire the dental segment ("HuFriedyGroup" or the "Company") of STERIS plc (NYSE:STE) ("STERIS"). Founded in 1908, HuFriedyGroup is a leading global manufacturer of high-quality instruments, infection prevention products, instrument management systems, and conscious sedation products for the dental industry. ...

A downtrend has been apparent in Steris (STE) lately with too much selling pressure. The stock has declined 9.1% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting w ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style S ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?T ...

Julie Winter STERIS plc (NYSE:STE) Q3 2024 Earnings Conference Call February 8, 2024 9:00 AM ET Julie Winter - Vice President of Investor Relations Dan Carestio - President & Chief Executive Officer Patrick Wood - Morgan Stanley Jacob Johnson - Stephens, Inc. Jason Bednar - Piper Sandler David Turkaly - JMP Securities Good morning everyone and welcome to the STERIS plc Third Quarter 2024 Conference Call. [Operator Instructions] Please also note today's event is being recorded. Julie Winter This webcast cont ...

STERIS plc (STE) reported third-quarter fiscal 2024 adjusted earnings per share (EPS) of $2.22, up 9.9% from the year-ago quarter’s figure. The metric surpassed the Zacks Consensus Estimate by 2.8%.The adjustment excludes the impacts of certain non-recurring charges like the amortization of acquired intangible assets and acquisition and integration-related charges, among others.The company’s GAAP EPS was $1.42, an increase of 14.5% from the year-ago period.  Revenues in DetailRevenues of $1.40 billion incre ...

Steris (STE) reported $1.4 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 14.8%. EPS of $2.22 for the same period compares to $2.02 a year ago.The reported revenue represents a surprise of +4.22% over the Zacks Consensus Estimate of $1.34 billion. With the consensus EPS estimate being $2.17, the EPS surprise was +2.30%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...

Steris (STE) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.30%. A quarter ago, it was expected that this medical products maker would post earnings of $2.05 per share when it actually produced earnings of $2.03, delivering a surprise of -0.98%.Over the last four quarters, the comp ...